Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2
- PMID: 35554919
- DOI: 10.1007/978-1-0716-2111-0_23
Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2
Abstract
In this chapter, we discuss potential incidents associated with SARS-CoV-2 experimental work in high containment research laboratories. The risk landscape in high containment laboratories is changing due to the strong innovation drive of the life sciences research. Thus, the WHO has recommended life sciences organizations to incorporate good research practices and ethical principles into a risk-based approach of the biorisk management (BRM). Currently, BRM systems in high containment laboratories are predominantly steered by operational personnel and laboratory professional. It is well known that without having a systematic approach and leadership support from the organization, the BRM system in the high containment laboratory will not be sustainable. Even though the roles of organizations and their leadership in establishing the BRM system are spelt out in many international standards, guidance documents and national legislations, operational aspects of these roles are rarely discussed.It is therefore important for everyone to understand about their roles in organizational processes (communication, decision, and performance evaluation) involved in implementation of BRM related operational activities. In this chapter, discussion is based on operational activities of four main organizational behaviors that are considered to have strengthened BRM systems in high containment laboratories: (1) displaying a visible commitment and support to the BRM system from different levels of management, (2) developing a competent and responsible workforce with BRM technical skills and problem identification/solving skills, (3) integrating learning and improvement principles into the BRM system, and (4) enhancing the continuous motivation of laboratory personnel to avoid complacency. The categorization of these organizational behaviors is based on the International Atomic Energy Agency's principles and guidance for strengthening the safety and security culture in nuclear facilities. Furthermore, we encourage the laboratory management to identify gaps in processes and activities related to those organizational behaviors so that one could rapidly address biosafety and biosecurity vulnerabilities in high containment laboratories.
Keywords: Biorisk management; Biosafety; Biosecurity; Organizational behaviors; Security-sensitive or high-risk biological agents.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.Methods Mol Biol. 2022;2452:441-464. doi: 10.1007/978-1-0716-2111-0_24. Methods Mol Biol. 2022. PMID: 35554920
-
Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.Euro Surveill. 2020 Sep;25(36):2000089. doi: 10.2807/1560-7917.ES.2020.25.36.2000089. Euro Surveill. 2020. PMID: 32914748 Free PMC article.
-
Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.Health Secur. 2022 Nov-Dec;20(6):479-487. doi: 10.1089/hs.2019.0069. Epub 2022 Nov 18. Health Secur. 2022. PMID: 36399610 Free PMC article.
-
[Biorisk Management for Clinical Diagnostic Laboratories].Rinsho Byori. 2016 Nov;64(11):1279-1289. Rinsho Byori. 2016. PMID: 30695310 Review. Japanese.
-
Motivating Proactive Biorisk Management.Health Secur. 2023 Jan-Feb;21(1):46-60. doi: 10.1089/hs.2022.0101. Epub 2023 Jan 12. Health Secur. 2023. PMID: 36633603 Free PMC article. Review.
Cited by
-
Biosafety status analysis and risk assessment of laboratories from 2021 to 2023 in Jiaxing, China.Front Bioeng Biotechnol. 2025 Apr 16;13:1442651. doi: 10.3389/fbioe.2025.1442651. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40309507 Free PMC article.
-
Towards a sense of urgency for innovation realization: a case study on complacency asymmetries in interorganizational relations.J Innov Entrep. 2023;12(1):11. doi: 10.1186/s13731-023-00267-2. Epub 2023 Mar 9. J Innov Entrep. 2023. PMID: 36919090 Free PMC article.
References
-
- WHO (2004) Laboratory biosafety manual, 3rd edn. WHO Press, Geneva
-
- WHO (2006) Biorisk management. Laboratory biosecurity guidance. WHO Press, Geneva
-
- National Institute of Environmental Health Sciences, UK. Bioethics. https://www.niehs.nih.gov/research/resources/bioethics/index.cfm . Accessed 23 Dec 2020
-
- WHO (2010) Responsible life sciences research for global health security. Guidance document. WHO Press, Geneva
-
- Biosecurity Office, National Institute for Public Health and the Environment, Netherlands. Dual-use research. https://www.bureaubiosecurity.nl/en/policy/dual-use-research . Accessed 23 Dec 2020
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous